Due to the high expression of E2F target genes in canine melanoma tissue samples, we further investigated the possibility of targeting the Rb-E2F pathway, as a new potential anticancer therapeutic approach for canine oral melanoma using a CDK4/6 inhibitor. The gene discussed is CDK4; the disease is melanoma.